National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, 117799the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, 117799the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211061051. doi: 10.1177/20587384211061051.
The spleen plays an important role in regulating the immune response to infectious pathogens. T-cells dysfunction and exhaustion have been reported in patients with hepatitis B/C virus (HBV/HCV) infection, which contributes to persistent virus infection. The aims of this study were to investigate spleen-related evidence of immunosuppression and immune tolerance in HCV cirrhotic patients with portal hypertension (PH). The expression of programmed cell death 1 (PD-1), T-cell immunoglobulin domain and mucin domain-containing molecule-3 (Tim-3) and its ligand PD-L1/2, and Galectin-9 in the spleens and livers of HCV cirrhotic patients ( = 15) was analyzed using real-time PCR and immunohistochemistry. Flow cytometry was used to evaluate the expression of PD-1 and Tim-3 on splenic T-cells and the peripheral blood T-cells before and after splenectomy ( = 8). Spleens from patients with PH showed significantly increased mRNA levels of PD-L2, Tim-3, Galectin-9, CD80, and CD86, and decreased levels of CD28 compared to control spleens (spleens removed due to traumatic injury) (all < 0.05). Additionally, protein expression of inhibitory signaling molecules was significantly increased in both the spleens and livers of cirrhotic patients compared with controls (all < 0.05). Peripheral blood and splenic CD4 and CD8 T-cells also expressed higher protein levels of PD-1, Tim-3, and CTLA-4 in cirrhotic patients as compared with healthy controls (all < 0.05). The proportion of PD-1CD4T lymphocytes (26.2% ± 7.12% vs. 21.0% ± 9.14%, = 0.0293) and Tim-3CD8 T lymphocytes (9.4% ± 3.04% vs. 6.0% ± 2.24%, = 0.0175) in peripheral blood decreased followed splenectomy. The CD4 and CD8 T-cells in spleen and peripheral blood highly expressed PD-1 and Tim-3 in HCV-infected and cirrhotic patients with portal hypertension. Highly expressed PD-1 and Tim-3 in peripheral blood T-lymphocytes can be partly reversed following splenectomy.
脾脏在调节对感染病原体的免疫反应方面起着重要作用。已有研究报道,乙型肝炎/丙型肝炎病毒(HBV/HCV)感染患者的 T 细胞功能障碍和耗竭,导致持续性病毒感染。本研究旨在探讨丙型肝炎肝硬化伴门静脉高压(PH)患者脾脏免疫抑制和免疫耐受的相关证据。使用实时 PCR 和免疫组织化学分析了 HCV 肝硬化患者(n=15)脾脏中程序性细胞死亡 1(PD-1)、T 细胞免疫球蛋白和粘蛋白结构域包含分子 3(Tim-3)及其配体 PD-L1/2 和半乳糖凝集素 9 的表达。流式细胞术用于评估脾切除术前后外周血 T 细胞中 PD-1 和 Tim-3 的表达(n=8)。与对照脾脏(因创伤性损伤而切除的脾脏)相比,PH 患者的脾脏显示出明显增加的 PD-L2、Tim-3、半乳糖凝集素 9、CD80 和 CD86 mRNA 水平,而 CD28 水平降低(均<0.05)。此外,与对照组相比,肝硬化患者的脾脏和肝脏中抑制性信号分子的蛋白表达也显著增加(均<0.05)。与健康对照组相比,肝硬化患者外周血和脾 CD4 和 CD8 T 细胞也表达更高水平的 PD-1、Tim-3 和 CTLA-4 蛋白(均<0.05)。脾切除术前后外周血 PD-1CD4T 淋巴细胞(26.2%±7.12%比 21.0%±9.14%,=0.0293)和 Tim-3CD8 T 淋巴细胞(9.4%±3.04%比 6.0%±2.24%,=0.0175)的比例降低。在感染 HCV 且伴有门静脉高压的肝硬化患者中,脾和外周血中的 CD4 和 CD8 T 细胞高度表达 PD-1 和 Tim-3。外周血 T 淋巴细胞中高表达的 PD-1 和 Tim-3 可在脾切除术后部分逆转。